tiprankstipranks
China Shineway Pharmaceutical Group Limited (HK:2877)
:2877
Hong Kong Market
2877
China Shineway Pharmaceutical Group Limited
RESEARCH TOOLSreports

China Shineway Pharmaceutical Group Limited (2877) Ratios

0 Followers

China Shineway Pharmaceutical Group Limited Ratios

HK:2877's free cash flow for Q2 2025 was ¥0.72. For the 2025 fiscal year, HK:2877's free cash flow was decreased by ¥ and operating cash flow was ¥0.22. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 3.71 3.51 3.35 4.07 5.19
Quick Ratio
 3.43 3.18 2.98 3.68 4.65
Cash Ratio
 2.86 2.51 2.42 3.02 3.83
Solvency Ratio
 0.37 0.39 0.45 0.49 0.57
Operating Cash Flow Ratio
 0.38 0.39 0.38 0.67 0.64
Short-Term Operating Cash Flow Coverage
 2.89 2.92 3.11 0.00 0.00
Net Current Asset Value
¥ 6.59B¥ 6.02B¥ 5.62B¥ 4.93B¥ 4.40B
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.03 <0.01 <0.01
Debt-to-Equity Ratio
 0.04 0.05 0.04 <0.01 <0.01
Debt-to-Capital Ratio
 0.04 0.04 0.04 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.34 1.34 1.36 1.29 1.22
Debt Service Coverage Ratio
 1.30 2.07 3.80 1.44K 590.36
Interest Coverage Ratio
 0.00 137.48 356.42 1.13K 426.13
Debt to Market Cap
 0.05 0.05 0.06 0.00 0.00
Interest Debt Per Share
 0.44 0.47 0.40 0.01 0.02
Net Debt to EBITDA
 -9.13 -5.78 -3.93 -4.55 -4.64
Profitability Margins
Gross Profit Margin
72.28%74.95%75.15%74.38%74.77%
EBIT Margin
21.76%22.13%27.52%23.23%22.38%
EBITDA Margin
24.14%26.52%31.44%27.93%28.04%
Operating Profit Margin
21.76%22.30%21.60%18.06%16.58%
Pretax Profit Margin
40.54%30.33%27.46%23.21%22.34%
Net Profit Margin
30.36%22.24%21.47%18.30%17.27%
Continuous Operations Profit Margin
30.36%22.24%21.47%18.30%17.27%
Net Income Per EBT
74.89%73.32%78.17%78.82%77.30%
EBT Per EBIT
186.30%135.97%127.14%128.51%134.76%
Return on Assets (ROA)
8.76%8.37%10.13%8.78%7.73%
Return on Equity (ROE)
11.90%11.25%13.78%11.32%9.43%
Return on Capital Employed (ROCE)
8.18%11.10%13.66%10.87%8.75%
Return on Invested Capital (ROIC)
5.89%7.79%10.25%8.58%6.78%
Return on Tangible Assets
8.91%8.53%10.34%9.01%7.98%
Earnings Yield
14.59%12.25%19.12%14.28%13.14%
Efficiency Ratios
Receivables Turnover
 3.11 3.14 3.58 4.05 3.91
Payables Turnover
 2.54 2.35 2.32 3.28 3.56
Inventory Turnover
 1.25 1.16 1.25 1.54 1.38
Fixed Asset Turnover
 2.49 3.10 3.75 3.25 2.57
Asset Turnover
 0.29 0.38 0.47 0.48 0.45
Working Capital Turnover Ratio
 0.47 0.64 0.83 0.81 0.72
Cash Conversion Cycle
 266.14 274.34 236.13 215.89 254.72
Days of Sales Outstanding
 117.40 116.11 101.86 90.09 93.43
Days of Inventory Outstanding
 292.72 313.66 291.93 237.12 263.90
Days of Payables Outstanding
 143.98 155.43 157.65 111.32 102.61
Operating Cycle
 410.12 429.77 393.78 327.21 357.33
Cash Flow Ratios
Operating Cash Flow Per Share
 1.28 1.27 1.23 1.47 0.93
Free Cash Flow Per Share
 1.06 1.09 1.04 1.30 0.81
CapEx Per Share
 0.22 0.19 0.19 0.17 0.12
Free Cash Flow to Operating Cash Flow
 0.83 0.85 0.85 0.88 0.87
Dividend Paid and CapEx Coverage Ratio
 1.85 1.76 2.02 2.99 1.29
Capital Expenditure Coverage Ratio
 5.81 6.87 6.46 8.57 7.51
Operating Cash Flow Coverage Ratio
 2.88 2.78 3.10 149.11 47.16
Operating Cash Flow to Sales Ratio
 0.31 0.25 0.21 0.28 0.22
Free Cash Flow Yield
12.34%12.00%15.54%19.36%14.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 6.85 8.17 5.23 7.00 7.61
Price-to-Sales (P/S) Ratio
 2.08 1.82 1.12 1.28 1.31
Price-to-Book (P/B) Ratio
 0.80 0.92 0.72 0.79 0.72
Price-to-Free Cash Flow (P/FCF) Ratio
 8.10 8.33 6.43 5.16 6.95
Price-to-Operating Cash Flow Ratio
 6.71 7.12 5.44 4.56 6.03
Price-to-Earnings Growth (PEG) Ratio
 0.47 -0.61 0.16 0.24 0.08
Price-to-Fair Value
 0.80 0.92 0.72 0.79 0.72
Enterprise Value Multiple
 -0.51 1.06 -0.36 0.04 0.05
Enterprise Value
 -383.70M 1.07B -515.64M 43.85M 46.45M
EV to EBITDA
 -0.51 1.06 -0.36 0.04 0.05
EV to Sales
 -0.12 0.28 -0.11 0.01 0.01
EV to Free Cash Flow
 -0.48 1.29 -0.65 0.04 0.08
EV to Operating Cash Flow
 -0.40 1.11 -0.55 0.04 0.07
Tangible Book Value Per Share
 10.44 9.62 9.03 8.17 7.51
Shareholders’ Equity Per Share
 10.68 9.87 9.29 8.45 7.82
Tax and Other Ratios
Effective Tax Rate
 0.25 0.27 0.22 0.21 0.23
Revenue Per Share
 4.12 4.99 5.96 5.23 4.27
Net Income Per Share
 1.25 1.11 1.28 0.96 0.74
Tax Burden
 0.75 0.73 0.78 0.79 0.77
Interest Burden
 1.86 1.37 1.00 1.00 1.00
Research & Development to Revenue
 0.03 0.03 0.02 0.03 0.03
SG&A to Revenue
 0.47 0.50 0.07 0.07 0.08
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 <0.01
Income Quality
 1.17 0.84 0.75 1.54 1.26
Currency in CNY